Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system

Details for Australian Patent Application No. 2010277554 (hide)

Owner Antisense Pharma GmbH

Inventors Schlingensiepen, Karl-Hermann; Jaschinski, Frank; Rothammer, Tanja; Schneider, Anneliese

Agent Davies Collison Cave

Pub. Number AU-A-2010277554

PCT Pub. Number WO2011/012713

Priority 09166893.9 30.07.09 EP

Filing date 30 July 2010

Wipo publication date 3 February 2011

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

Event Publications

1 March 2012 PCT application entered the National Phase

  PCT publication WO2011/012713 Priority application(s): WO2011/012713

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010277555-Algae reactor

2010277553-Method for manufacturing a mineral fibre-containing element and element produced by that method